(JRVR) James River Holdings - Ratings and Ratios
Excess, Surplus, Liability, Property, Admitted, Fronting
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.65% |
| Yield on Cost 5y | 0.08% |
| Yield CAGR 5y | -57.27% |
| Payout Consistency | 77.9% |
| Payout Ratio | 80.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 49.3% |
| Value at Risk 5%th | 71.0% |
| Relative Tail Risk | -12.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | 15.05 |
| CAGR/Max DD | -0.39 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.322 |
| Beta | 0.531 |
| Beta Downside | 0.274 |
| Drawdowns 3y | |
|---|---|
| Max DD | 85.36% |
| Mean DD | 58.89% |
| Median DD | 68.49% |
Description: JRVR James River Holdings January 01, 2026
James River Group Holdings, Inc. (NASDAQ:JRVR) is a specialty insurer that operates two distinct lines of business: an Excess & Surplus (E&S) segment that writes liability and property coverage in the U.S. mainland, Puerto Rico and the U.S. Virgin Islands, and a Specialty Admitted segment that supplies fronting, program-administration and managing-general-agent (MGA) solutions to other carriers. The E&S business is primarily distributed through wholesale brokers, while the admitted segment serves as a conduit for larger insurers to access niche markets.
Key operational metrics (FY 2023) show a combined ratio of 95.8% in the E&S line, indicating underwriting profitability, and a net income of $23 million on $1.2 billion of written premium. The company’s earnings per share (EPS) grew 12% year-over-year, driven by higher premium volume and disciplined loss reserving.
Sector drivers that materially affect JRVR include the frequency of natural-catastrophe events in its property exposure zones, which can swing loss ratios by several points, and the broader interest-rate environment that influences investment income on its float. Additionally, the ongoing consolidation in the wholesale broker market tends to concentrate distribution power, potentially improving pricing power for carriers that maintain strong broker relationships.
For a deeper quantitative view, you may find ValueRay’s analyst dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-49.4m TTM) > 0 and > 6% of Revenue (6% = 38.8m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 5.65pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 243.6% (prev 446.7%; Δ -203.1pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 15.5m > Net Income -49.4m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 8.45 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.5m) change vs 12m ago 22.65% (target <= -2.0% for YES) |
| Gross Margin 15.83% (prev 47.76%; Δ -31.93pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.05% (prev 14.07%; Δ -1.02pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.99 (EBITDA TTM -22.6m / Interest Expense TTM 23.3m) >= 6 (WARN >= 3) |
Altman Z'' 1.69
| (A) 0.32 = (Total Current Assets 1.79b - Total Current Liabilities 211.3m) / Total Assets 4.95b |
| (B) -0.08 = Retained Earnings (Balance) -394.4m / Total Assets 4.95b |
| (C) -0.00 = EBIT TTM -23.0m / Avg Total Assets 4.95b |
| (D) -0.10 = Book Value of Equity -433.4m / Total Liabilities 4.31b |
| Total Rating: 1.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 28.75
| 1. Piotroski 0.0pt |
| 2. FCF Yield -3.44% |
| 3. FCF Margin 1.61% |
| 4. Debt/Equity 0.52 |
| 5. Debt/Ebitda -4.02 |
| 6. ROIC - WACC (= -6.06)% |
| 7. RoE -7.99% |
| 8. Rev. Trend -44.18% |
| 9. EPS Trend -51.48% |
What is the price of JRVR shares?
Over the past week, the price has changed by -3.91%, over one month by +2.48%, over three months by +13.01% and over the past year by +28.82%.
Is JRVR a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the JRVR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.3 | 17.9% |
| Analysts Target Price | 7.3 | 17.9% |
| ValueRay Target Price | 5.3 | -14% |
JRVR Fundamental Data Overview January 01, 2026
P/E Forward = 5.7703
P/S = 0.455
P/B = 0.5841
Beta = 0.018
Revenue TTM = 646.6m USD
EBIT TTM = -23.0m USD
EBITDA TTM = -22.6m USD
Long Term Debt = 329.9m USD (from longTermDebt, last quarter)
Short Term Debt = 3.15m USD (from shortTermDebt, last fiscal year)
Debt = 329.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 91.1m USD (from netDebt column, last quarter)
Enterprise Value = -302.1m USD (294.2m + Debt 329.9m - CCE 926.2m)
Interest Coverage Ratio = -0.99 (Ebit TTM -23.0m / Interest Expense TTM 23.3m)
FCF Yield = -3.44% (FCF TTM 10.4m / Enterprise Value -302.1m)
FCF Margin = 1.61% (FCF TTM 10.4m / Revenue TTM 646.6m)
Net Margin = -7.64% (Net Income TTM -49.4m / Revenue TTM 646.6m)
Gross Margin = 15.83% ((Revenue TTM 646.6m - Cost of Revenue TTM 544.2m) / Revenue TTM)
Gross Margin QoQ = 21.10% (prev 25.34%)
Tobins Q-Ratio = -0.06 (set to none) (Enterprise Value -302.1m / Total Assets 4.95b)
Interest Expense / Debt = 1.89% (Interest Expense 6.22m / Debt 329.9m)
Taxrate = 39.93% (1.06m / 2.65m)
NOPAT = -13.8m (EBIT -23.0m * (1 - 39.93%)) [loss with tax shield]
Current Ratio = 8.45 (Total Current Assets 1.79b / Total Current Liabilities 211.3m)
Debt / Equity = 0.52 (Debt 329.9m / totalStockholderEquity, last quarter 636.8m)
Debt / EBITDA = -4.02 (negative EBITDA) (Net Debt 91.1m / EBITDA -22.6m)
Debt / FCF = 8.76 (Net Debt 91.1m / FCF TTM 10.4m)
Total Stockholder Equity = 618.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.00% (Net Income -49.4m / Total Assets 4.95b)
RoE = -7.99% (Net Income TTM -49.4m / Total Stockholder Equity 618.5m)
RoCE = -2.43% (EBIT -23.0m / Capital Employed (Equity 618.5m + L.T.Debt 329.9m))
RoIC = -1.71% (negative operating profit) (NOPAT -13.8m / Invested Capital 809.0m)
WACC = 4.36% (E(294.2m)/V(624.0m) * Re(7.97%) + D(329.9m)/V(624.0m) * Rd(1.89%) * (1-Tc(0.40)))
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 11.08%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈10.4m ; Y1≈6.83m ; Y5≈3.12m
Fair Price DCF = 1.34 (DCF Value 61.4m / Shares Outstanding 46.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -51.48 | EPS CAGR: -7.86% | SUE: -1.13 | # QB: 0
Revenue Correlation: -44.18 | Revenue CAGR: -4.75% | SUE: -0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.18 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+5.2% | Growth Revenue=+0.2%
Additional Sources for JRVR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle